Estefania Linares
La Paz, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
PSA Response as a Prognostic Factor of Overall Survival in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Real-world Evidence.
Journal: European urology open science
Published: March 31, 2026
Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study.
Journal: European urology oncology
Published: November 17, 2025
Comparing Prostatype P-score and traditional risk models for predicting prostate cancer outcomes in Spain.
Journal: Actas urologicas espanolas
Published: January 27, 2025
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy.
Journal: European urology open science
Published: February 02, 2024
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC).
Journal: Frontiers in oncology
Published: December 01, 2022
Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263].
Journal: European urology oncology
Published: May 05, 2021
Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry.
Journal: Clinical genitourinary cancer
Published: October 19, 2020
Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis.
Journal: Minerva urology and nephrology
Published: September 30, 2020
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC).
Journal: European urology oncology
Published: September 21, 2020
Outcomes of minimally invasive partial nephrectomy among very elderly patients: report from the RESURGE collaborative international database.
Journal: Central European journal of urology
Published: June 17, 2020
Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group.
Journal: European urology focus
Published: November 13, 2018
Last Updated: 09/26/2026